• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定及鉴定呋塞米1-O-酰基葡萄糖醛酸苷的酰基迁移和光降解产物

High-performance liquid chromatographic determination and identification of acyl migration and photodegradation products of furosemide 1-O-acyl glucuronide.

作者信息

Mizuma T, Benet L Z, Lin E T

机构信息

Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Hachioji, Japan.

出版信息

J Chromatogr B Biomed Sci Appl. 1998 Oct 23;718(1):153-62. doi: 10.1016/s0378-4347(98)00357-0.

DOI:10.1016/s0378-4347(98)00357-0
PMID:9832372
Abstract

Stability of furosemide glucuronide, the major metabolite of furosemide, was studied in order to accurately assess the glucuronidation of furosemide. Furosemide glucuronide was purified by high-performance liquid chromatography, and the mass spectrum of furosemide glucuronide showed the molecular ion peaks [M-H]- at 505 and 507 (m/z). Furosemide glucuronide was photodegraded to the compound, which was shown more hydrophilic than furosemide glucuronide by high-performance liquid chromatography assay. The photodegradation product of furosemide glucuronide was hydrolyzed to one of the photodegradation products of furosemide by beta-glucuronidase, indicating that the photodegradation product of furosemide glucuronide possessed a glucuronic acid moiety. Furthermore, the mass spectrum of the photodegradation product of furosemide glucuronide exhibited molecular ion peaks [M-H]- at 487 and [M-2H+2Na]- at 509, indicating the chlorine displacement of furosemide glucuronide by a hydroxyl group. Furosemide glucuronide was unstable in an aqueous solution (pH=7.4), and presumed acyl migration isomers of furosemide glucuronide (furosemide glucuronide-isomers) were detected by high-performance liquid chromatography equipped with photodiode array UV detector. The UV spectra of seven furosemide glucuronide-isomers were closely similar to that of furosemide glucuronide but not furosemide. Exposing a mixture of furosemide glucuronide and furosemide glucuronide-isomers to light resulted in the production of new compounds. UV spectra of photodegradation products of furosemide glucuronide-isomers were closely similar to those of photodegradation product of furosemide glucuronide. These results suggested that furosemide glucuronide-isomers were also photodegraded, resulting in the displacement of chlorine by a hydroxyl group as in furosemide glucuronide.

摘要

为准确评估呋塞米的葡萄糖醛酸化作用,对其主要代谢产物呋塞米葡萄糖醛酸苷的稳定性进行了研究。通过高效液相色谱法对呋塞米葡萄糖醛酸苷进行纯化,呋塞米葡萄糖醛酸苷的质谱显示分子离子峰[M-H]- 位于505和507(m/z)处。呋塞米葡萄糖醛酸苷经光降解生成一种化合物,通过高效液相色谱分析表明该化合物比呋塞米葡萄糖醛酸苷更具亲水性。呋塞米葡萄糖醛酸苷的光降解产物经β-葡萄糖醛酸酶水解为呋塞米的一种光降解产物,表明呋塞米葡萄糖醛酸苷的光降解产物含有葡萄糖醛酸部分。此外,呋塞米葡萄糖醛酸苷光降解产物的质谱显示分子离子峰[M-H]- 位于487处,[M-2H+2Na]- 位于509处,表明呋塞米葡萄糖醛酸苷中的氯被羟基取代。呋塞米葡萄糖醛酸苷在水溶液(pH = 7.4)中不稳定,通过配备光电二极管阵列紫外检测器的高效液相色谱法检测到了推测的呋塞米葡萄糖醛酸苷酰基迁移异构体(呋塞米葡萄糖醛酸苷异构体)。七种呋塞米葡萄糖醛酸苷异构体的紫外光谱与呋塞米葡萄糖醛酸苷的紫外光谱非常相似,但与呋塞米的紫外光谱不同。将呋塞米葡萄糖醛酸苷和呋塞米葡萄糖醛酸苷异构体的混合物暴露于光下会产生新的化合物。呋塞米葡萄糖醛酸苷异构体的光降解产物的紫外光谱与呋塞米葡萄糖醛酸苷的光降解产物的紫外光谱非常相似。这些结果表明,呋塞米葡萄糖醛酸苷异构体也会发生光降解,导致氯被羟基取代,如同呋塞米葡萄糖醛酸苷一样。

相似文献

1
High-performance liquid chromatographic determination and identification of acyl migration and photodegradation products of furosemide 1-O-acyl glucuronide.高效液相色谱法测定及鉴定呋塞米1-O-酰基葡萄糖醛酸苷的酰基迁移和光降解产物
J Chromatogr B Biomed Sci Appl. 1998 Oct 23;718(1):153-62. doi: 10.1016/s0378-4347(98)00357-0.
2
Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
Drug Metab Dispos. 1985 Nov-Dec;13(6):705-10.
3
Apparent intramolecular acyl migration and hydrolysis of furosemide glucuronide in aqueous solution.呋塞米葡萄糖醛酸苷在水溶液中的表观分子内酰基迁移和水解
Biol Pharm Bull. 1995 Jan;18(1):134-9. doi: 10.1248/bpb.18.134.
4
Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid.采用直接梯度高效液相色谱荧光检测法测定人血浆和尿液中呋塞米及其酰基葡萄糖醛酸苷。丙磺舒的初步药代动力学及作用。
J Chromatogr B Biomed Appl. 1994 Apr 22;655(1):53-62. doi: 10.1016/0378-4347(94)00093-x.
5
Preparative chromatography of furosemide 1-O-acyl-glucuronide from urine using micronized amberiite XAD-2 and its application to other 1-O-acyl-glucuronides.使用微粉化的琥珀色XAD-2从尿液中制备速尿1-O-酰基葡萄糖醛酸苷及其在其他1-O-酰基葡萄糖醛酸苷中的应用。
Prep Biochem Biotechnol. 1998 Feb;28(1):37-47. doi: 10.1080/10826069808010125.
6
Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans.
J Pharm Pharmacol. 1999 Mar;51(3):239-48. doi: 10.1211/0022357991772402.
7
LC-1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems.液相色谱-核磁共振联用技术用于测定S-萘普生葡萄糖醛酸苷异构体在两种等度反相液相色谱系统中的洗脱顺序。
J Pharm Biomed Anal. 2001 Jan;24(3):477-85. doi: 10.1016/s0731-7085(00)00453-2.
8
Optimization to eliminate the interference of migration isomers for measuring 1-O-beta-acyl glucuronide without extensive chromatographic separation.在无需广泛色谱分离的情况下,进行优化以消除迁移异构体对1-O-β-酰基葡萄糖醛酸苷测量的干扰。
Rapid Commun Mass Spectrom. 2008;22(2):109-20. doi: 10.1002/rcm.3339.
9
Identification of Furosemide Photodegradation Products in Water-Acetonitrile Mixture.水-乙腈混合物中呋塞米光降解产物的鉴定
Chem Pharm Bull (Tokyo). 2015;63(8):617-27. doi: 10.1248/cpb.c15-00122.
10
S-naproxen-beta-1-O-acyl glucuronide degradation kinetic studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV.通过停流高效液相色谱-核磁共振氢谱和高效液相色谱-紫外联用技术对S-萘普生-β-1-O-酰基葡萄糖醛酸苷降解动力学的研究
Drug Metab Dispos. 2001 Apr;29(4 Pt 1):375-80.

引用本文的文献

1
Photoinduced covalent binding of frusemide and frusemide glucuronide to human serum albumin.速尿和速尿葡萄糖醛酸苷与人血清白蛋白的光诱导共价结合。
Br J Clin Pharmacol. 1999 Jul;48(1):79-87. doi: 10.1046/j.1365-2125.1999.00970.x.